Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India Drug Research Support Program Given Quiet Death

This article was originally published in PharmAsia News

Executive Summary

India's seven-year program aimed at supporting pharmaceutical research has been allowed to die. An official with the Department of Science and Technology confirmed the fund has been dissolved, replaced by the general funds of the ministry. Begun in the 2000-2001 budget, the fund became controversial from the beginning and encountered jurisdictional problems between the DST and the Chemicals and Fertilizers Ministry. Ending up in the DST, only the interest from the fund became available to the industry to support the expensive drug-development process. An industry representative also cited a problem with company reluctance to share research data with a government agency. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067650

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel